SMID Biotech Stocks Stalled and are Lacking Momentum
SMID Biotechs Stalled but a Strong Week for Most Large Caps Large CAPs biopharmas did better during a volaiile week for AI and NASDAQ. SMIDs in a Red screen mode with XBI down 6%, IWM down 3%. BIG Winners for the week:AMGN, BIIB, LLY, PFE. ;XLV up 13.74% YTD. Another Rotation week? AI trade is...
Biotech Stocks: Larger Caps are Favored until Momentum Returns…Update-2
Update-2….1016/26- ….Tech wreck continues with focus on AI infrastructure funding and capital. Need to see if broadening of market and new leadership emerges outside of tech. such as healthcare. Rebalancing can focus on large cap biopharma and energy. RISK off for SMID biotechs...
Biotech Bull Market Opportunities: Away from the madding crowd of compute?…Update-5
Update-5…10/9/26..3:17p EDT ALERT: Out of Nowhere comes a GREEN SCREEN in biotech!! IBB and XBI up 3%. Update-4 10/726 …Massive selling in ARKG yesterday took many genomics stocks down , now trading at about $50, down 7.58% over 5 days. Still In the bubble though up 73% YTD....
Biotech Stocks Slip into a Red Screen Day as the Market Hits the Snag of Geopolitical Tensions…Update-1
Update-1 Biotech and healthcare stocks look pretty good right now with many large caps still near their highs even Biogen (BIIB) at $228. The IBB at $209 has recovered from the mid-month sell-off. The XBI has lost momentum down 8% for the month, but should rally into the end of Q4, but we are...
Healthcare Sector Update after a Tough Week, Looking for Gains Ahead in Biotech…Update-1 Genomics stocks soar!
Update-1 SMID biotech movers today-Morgan Stanley Healthcare presentation– from our Focus Trading List: Many of these stocks are in the Cathy Wood managed ETF (ARKG). A green screen day in GENOMICS. We are long all of them. Adaptive Biotechnologies (ADPT) up 7.67% to $27. Cryoport (CYRX)...
